|
PCYT1A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.820400E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.813200E-01 |
| Normal-vs-Stage2 |
2.543700E-02 |
| Normal-vs-Stage3 |
3.092100E-02 |
| Normal-vs-Stage4 |
1.039420E-01 |
| Stage1-vs-Stage2 |
4.432100E-02 |
| Stage1-vs-Stage3 |
6.463800E-02 |
| Stage1-vs-Stage4 |
1.453400E-01 |
| Stage2-vs-Stage3 |
7.738400E-01 |
| Stage2-vs-Stage4 |
7.208200E-01 |
| Stage3-vs-Stage4 |
9.222800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.242400E-02 |
| Normal-vs-AfricanAmerican |
5.474000E-01 |
| Normal-vs-Asian |
1.012640E-01 |
| Caucasian-vs-AfricanAmerican |
9.496000E-01 |
| Caucasian-vs-Asian |
1.899780E-03 |
| AfricanAmerican-vs-Asian |
1.010420E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.000900E-03 |
| Normal-vs-Female |
7.822400E-01 |
| Male-vs-Female |
1.206280E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.926400E-01 |
| Normal-vs-Age(41-60Yrs) |
5.765600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.837800E-02 |
| Normal-vs-Age(81-100Yrs) |
2.764600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.985000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.686200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.166200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.202350E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.250600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.958600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.691200E-01 |
| Normal-vs-Grade 2 |
1.103170E-01 |
| Normal-vs-Grade 3 |
9.740400E-02 |
| Normal-vs-Grade 4 |
5.140400E-02 |
| Grade 1-vs-Grade 2 |
2.032200E-01 |
| Grade 1-vs-Grade 3 |
1.955820E-01 |
| Grade 1-vs-Grade 4 |
1.589160E-01 |
| Grade 2-vs-Grade 3 |
8.304000E-01 |
| Grade 2-vs-Grade 4 |
3.050800E-01 |
| Grade 3-vs-Grade 4 |
4.391600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.348600E-01 |
| Normal-vs-ccB subtype |
2.693200E-01 |
| ccA subtype-vs-ccB subtype |
5.606600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.476170E-01 |
| Normal-vs-N1 |
7.604800E-01 |
| N0-vs-N1 |
5.276200E-01 |
|
|
